Role of Single Nucleotide Variants in FSHR , GNRHR , ESR2 and LHCGR Genes in Adolescents with Polycystic Ovary Syndrome

• Published in: Diagnostics (Basel) 2021-12, Vol.11 (12), p.2327
• Main Authors: Lidaka, Lasma, Bekere, Laine, Rota, Adele, Isakova, Jekaterina, Lazdane, Gunta, Kivite-Urtane, Anda, Dzivite-Krisane, Iveta, Kempa, Inga, Dobele, Zane, Gailite, Linda
• Format: Article
• Language: English
• Subjects: Acne; adolescents; Age; Body mass index; ESR2; FSHR; genetics; GNRHR; Gynecology; Hospitals; Laboratories; LHCGR; Menstruation; Ovaries; Patients; Polycystic ovary syndrome; Population; Signal transduction; Software; State budgets; Teenagers; Ultrasonic imaging
• ISSN: 2075-4418; 2075-4418
• DOI: 10.3390/diagnostics11122327

Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in women, affecting up to 16.6% of reproductive-age women. PCOS symptoms in adolescents comprise oligomenorrhoea/amenorrhoea and biochemical and/or clinical hyperandrogenism. Long-term health risks of PCOS patients include infertility, metabolic syndrome, type 2 diabetes and cardiovascular disease. Genetic factors have been proven to play a role in development of the syndrome and its symptoms. To investigate single nucleotide variants (SNVs) in the and genes in adolescent patients with PCOS and their association with PCOS symptoms. We conducted a cross-sectional study comprising of 152 adolescents: 63 patients with PCOS, 22 patients at risk of developing PCOS and 67 healthy controls. Participants were recruited from out-patients attending a gynaecologist at the Children's Clinical University Hospital, Riga, Latvia, between January 2017 and December 2020. Genomic DNA was extracted from whole blood, and SNVs in the and genes were genotyped. The distributions of SNV genotypes were compared among the three groups and genotype-phenotype associations within the PCOS group were evaluated. No statistically significant differences were found in the distributions of genotypes for (rs104893837), (rs4986938), (rs2293275) and (rs6166, rs6165, rs2349415) among PCOS patients, risk patients and healthy controls. Within the PCOS group, rs4986938 minor allele homozygous patients had a significantly higher level of total testosterone than major allele homozygous patients and heterozygous patients. A significantly higher total testosterone level was also observed in PCOS patients carrying the rs2293275 minor allele compared with major allele homozygous patients. The SNVs rs4986938 and rs2293275 play a role in the phenotypic characteristics of PCOS. To fully uncover their influence on the development of PCOS and its symptoms, further studies of larger cohorts and a follow up of this study sample through to adulthood are required. Furthermore, studies of adolescent PCOS patients conducted prior to the latest European Society of Human Reproduction and Embryology (ESHRE) criteria (2018) should be re-evaluated as the study groups might include risk patients according to these updated criteria, thereby potentially significantly impacting the published results.